FDA Approves New Non-Opioid Painkiller, Journavx: 'No Addiction Potential'
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
The Associated Press on MSN12d
FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Everyday Health12d
FDA Approves First New Type of Pain Medication in More Than 20 Years
The U.S. Food and Drug Administration (FDA) has approved suzetrigine, the first drug in a new family of non-opioid painkillers to treat moderate-to-severe acute pain. Suzetrigine, to be sold under ...
AOL11d
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
Vertex began researching the drug in the 2000s when overdoses were rocketing upward, principally driven by mass prescribing of opioid painkillers for common ailments like arthritis and back pain.
Cleveland.com12d
FDA approves new painkiller designed to avoid opioid addiction risk
Vertex began researching the drug in the 2000s, when overdoses were rocketing upward, principally driven by mass prescribing of opioid painkillers for common ailments like arthritis and back pain.
Yahoo Finance11d
The FDA approved a new non-opioid painkiller. Its maker's stock is rising
More than 80 million people are prescribed medicine for acute pain every year, according to Vertex. The company said Journavx is the only approved non-opioid painkiller and the first new class of ...
The Boston Globe11d
At $31 a day, is Vertex’s new non-addictive painkiller worth the price?
Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at least as effective and costs only 50 cents a pill? They will if the ...
CBS News11d
FDA OK's painkiller designed to end opioids' addiction and overdose risk
principally driven by mass prescribing of opioid painkillers for common ailments like arthritis and back pain. Prescriptions have fallen sharply in the last decade and the current wave of the ...
The Columbian12d
FDA approves new painkiller that shows promise and challenges of opioid alternatives
principally driven by mass prescribing of opioid painkillers for common ailments like arthritis and back pain. Prescriptions have fallen sharply in the last decade and the current wave of the ...
Voice of America12d
FDA approves painkiller designed to eliminate risk of addiction
Vertex began researching the drug in the 2000s, when overdoses were rocketing upward, principally driven by mass prescribing of opioid painkillers for common ailments like arthritis and back pain.